Applied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2025 Earnings Call Transcript February 13, 2025
Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.32.
Operator: Good day, and welcome to the Applied DNA Sciences First Quarter Fiscal 2025 Financial Results. All participants will be in listen-only mode. Please note this event is being recorded. I would now like to turn the conference over to Sanjay Hurry, Head of Investor Relations. Please...
